Poseida Therapeutics, Inc.
NASDAQ:PSTX
9.5 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 44.472 | 81.378 | 206.325 | 83.966 | 87.784 | 30.395 | 15.625 | 17.892 |
| Short Term Investments
| 167.73 | 201.115 | 0 | 225.186 | 37.534 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 212.202 | 282.493 | 206.325 | 309.152 | 125.318 | 30.395 | 15.625 | 17.892 |
| Net Receivables
| 9.01 | 9.088 | 0 | 0 | 0 | 0 | 0 | 0.865 |
| Inventory
| 0 | 4.464 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.263 | 6.982 | 7.548 | 4.844 | 1.861 | 2.245 | 0.201 | 0.357 |
| Total Current Assets
| 226.475 | 298.563 | 213.873 | 313.996 | 127.179 | 32.64 | 15.826 | 19.114 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 40.781 | 46.671 | 48.227 | 48.322 | 10.858 | 3.416 | 1.725 | 1.892 |
| Goodwill
| 4.228 | 4.228 | 4.228 | 4.228 | 4.228 | 4.228 | 4.228 | 4.228 |
| Intangible Assets
| 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 2.604 | 2.892 |
| Goodwill and Intangible Assets
| 5.548 | 5.548 | 5.548 | 5.548 | 5.548 | 5.548 | 6.832 | 7.12 |
| Long Term Investments
| 0 | -9.224 | -8.926 | -9.125 | -1.609 | 0 | 0 | 0 |
| Tax Assets
| 0 | 9.224 | 8.926 | 9.125 | 1.609 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.081 | 1.055 | 1.661 | 3.618 | 3.411 | 3.516 | 1.07 | 0.064 |
| Total Non-Current Assets
| 47.41 | 53.274 | 55.436 | 57.488 | 19.817 | 12.48 | 9.627 | 9.076 |
| Total Assets
| 273.885 | 351.837 | 269.309 | 371.484 | 146.996 | 45.12 | 25.454 | 28.19 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 3.267 | 2.228 | 8.961 | 0.763 | 4.929 | 2.856 | 1.164 | 1.186 |
| Short Term Debt
| 20.572 | 11.732 | 12.674 | 9.616 | 3 | 0 | 1.111 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 31.008 | 19.723 | 4.497 | 22.615 | 12.255 | 0 | 2.298 | 2.708 |
| Other Current Liabilities
| 31.092 | 20.202 | 17.203 | 19.646 | 13.926 | 10.169 | 4.97 | 6.772 |
| Total Current Liabilities
| 71.318 | 53.885 | 43.335 | 30.025 | 21.855 | 13.025 | 7.245 | 10.666 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 79.472 | 107.522 | 80.365 | 54.507 | 26.14 | 19.086 | -33.824 | 0 |
| Deferred Revenue Non-Current
| 16.78 | 21.333 | 9.265 | 23.755 | 243.036 | 89.001 | 42.421 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.055 | 0.055 | 0.055 | 0.055 | 0.055 | 0.257 | 0.785 |
| Other Non-Current Liabilities
| 2.614 | -18.553 | -19.922 | 24.929 | 5.421 | 0.671 | -41.943 | 0.321 |
| Total Non-Current Liabilities
| 98.866 | 110.357 | 69.763 | 79.491 | 274.652 | 108.813 | 51.753 | 1.106 |
| Total Liabilities
| 170.184 | 164.242 | 113.098 | 109.516 | 296.507 | 121.838 | 58.998 | 11.772 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 371.484 | 222.173 | 72.46 | 42.145 | 31.063 |
| Common Stock
| 0.01 | 0.009 | 0.006 | 0.006 | 0.002 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -594.291 | -470.861 | -406.859 | -281.885 | -152.221 | -65.694 | -21.29 | -1.628 |
| Accumulated Other Comprehensive Income/Loss
| 0.126 | -0.149 | 0 | 0.005 | 0.019 | -1.015 | -0.55 | -13.018 |
| Other Total Stockholders Equity
| 697.856 | 658.596 | 563.064 | 543.842 | -222.173 | -51.423 | -18.187 | 0 |
| Total Shareholders Equity
| 103.701 | 187.595 | 156.211 | 261.968 | -149.511 | -76.718 | -33.544 | 16.418 |
| Total Equity
| 103.701 | 187.595 | 156.211 | 261.968 | -149.511 | -76.718 | -33.544 | 16.418 |
| Total Liabilities & Shareholders Equity
| 273.885 | 351.837 | 269.309 | 371.484 | 146.996 | 45.12 | 25.454 | 28.19 |